www.fdanews.com/articles/122957-elan-receives-first-japanese-product-approval-using-nanocrystal-technology
Elan Receives First Japanese Product Approval Using NanoCrystal Technology
December 14, 2009
Elan Drug Technologies, a business unit of Elan Corporation,
plc announces the approval by the Japanese Ministry of Health, Labour and Welfare of EMEND (aprepitant) for the treatment of cancer chemotherapy-induced
nausea and vomiting.
Benzinga
Benzinga